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Abstract
We previously reported that mice with skin-specific deletion of stearoyl-CoA desaturase-1 (Scd1) recapitulated the skin
phenotype and hypermetabolism observed in mice with a whole-body deletion of Scd1. In this study, we first performed a
diet-induced obesity experiment at thermoneutral temperature (33uC) and found that skin-specific Scd1 knockout (SKO)
mice still remain resistant to obesity. To elucidate the metabolic changes in the skin that contribute to the obesity resistance
and skin phenotype, we performed microarray analysis of skin gene expression in male SKO and control mice fed a standard
rodent diet. We identified an extraordinary number of differentially expressed genes that support the previously
documented histological observations of sebaceous gland hypoplasia, inflammation and epidermal hyperplasia in SKO
mice. Additionally, transcript levels were reduced in skin of SKO mice for genes involved in fatty acid synthesis, elongation
and desaturation, which may be attributed to decreased abundance of key transcription factors including SREBP1c, ChREBP
and LXRa. Conversely, genes involved in cholesterol synthesis were increased, suggesting an imbalance between skin fatty
acid and cholesterol synthesis. Unexpectedly, we observed a robust elevation in skin retinol, retinoic acid and retinoic acid-
induced genes in SKO mice. Furthermore, SEB-1 sebocytes treated with retinol and SCD inhibitor also display an elevation in
retinoic acid-induced genes. These results highlight the importance of monounsaturated fatty acid synthesis for maintaining
retinol homeostasis and point to disturbed retinol metabolism as a novel contributor to the Scd1 deficiency-induced skin
phenotype.
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Introduction
The epidermis has a large capacity for synthesizing both fatty
acids and cholesterol, which are utilized to form a variety of
complex lipids including phospholipids, triglycerides, sphingolip-
ids, esterified cholesterol, wax esters and retinyl esters [1,2,3].
These epidermal lipids are essential for maintaining a permeability
barrier that protects against transepidermal loss of water and
electrolytes, as well as providing an anti-microbial barrier that
prevents microorganism colonization and infection [1,3,4].
Disruption of the epidermal barrier stimulates both sterol and
fatty acid synthesis, an adaptation that aids in the restoration of
normal barrier function [3].
Skin is a stratified tissue composed of the epidermis, dermis and
subcutaneous fat layers. The epidermis is the thinnest of the three
layers, but mitotically is the most active layer due to the continuous
differentiation of keratinocytes into the cornified epithelium,
which is exposed to the environment. The dermis is thicker than
the epidermis and is composed largely of fibroblasts, which
surround the vasculature, nerves, immune cells, hair follicle and
the attached sebaceous gland. The major function of sebaceous
gland is to release lipid complex-lubricants, termed sebum, into the
sebaceous duct and hair follicle via rupture of differentiated
sebocytes [2]. However, the sebaceous gland has also been
proposed to be involved in antioxidant and antibacterial effects,
pheromone transport and epidermal hydration [2,5]. Sebum
contains triglycerides, diglycerides, fatty acids, cholesterol, choles-
teryl esters, squalene and wax esters [2]. Whereas overproduction
of sebum by the sebaceous gland contributes to the development of
acne and seborrhea, inadequate sebum production due to sebocyte
dysfunction impairs the function of the hair follicle [2].
SCD1 is highly expressed in the sebaceous gland and is not
observed in the hair follicle or any other cell type in mouse skin
[6]. Mice with a whole-body or skin-specific deletion of Scd1
develop severe sebaceous gland hypoplasia that results in pro-
gressive scarring alopecia, indicating that SCD1 is critical for
normal sebaceous gland function [6,7,8,9]. SCD1 is a D9 fatty acid
desaturase that primarily catalyzes the conversion of the saturated
fatty acids palmitic acid (16:0) and stearic acid (18:0) into the cis-
monounsaturated fatty acids (MUFA) palmitoleic acid (16:1n7)
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important esterification substrates in the formation of triglycerides,
cholesterol esters and wax esters, which are components of the
sebum [7,11]. Both whole-body and skin-specific deletion of Scd1
cause a remarkable hypermetabolic phenotype that protects
against the development of both genetic- and diet-induced obesity,
fatty liver and insulin resistance [7,8,12,13,14,15,16]. These
metabolic phenotypes persist despite hyperphagia, suggesting that
their obesity resistance is derived from an increase in energy
expenditure. Scd1-deficient mice are also cold intolerant, suggest-
ing that they have increased cold perception and/or loss of heat to
the environment [7,13,17]. The increased energy expenditure in
these mice has been hypothesized to be due to upregulation of
thermogenic processes for temperature maintenance at the
expense of fuel economy [7,13]. However, the exact mechanism
by which reduced sebaceous gland MUFA synthesis in the skin
elicits signals to cause hypermetabolism has not been determined.
In the current study, we performed microarray analysis of skin
gene expression using Affymetrix 430 2.0 arrays to explore the
cellular mechanisms responsible for the sebaceous gland hypopla-
sia and associated skin phenotypes in mice with skin-specific
deletion of Scd1 (SKO mice). The gene expression profile supports
the previous histological observations of sebaceous gland hypo-
plasia, inflammation, hyperkeratosis, epidermal hyperplasia and
tissue remodeling [18]. Additionally, the gene expression pattern
suggests an imbalance in skin lipogenesis characterized by
increased sterol synthesis but decreased fatty acid synthesis and
alterations in fatty acid composition. Unexpectedly, retinoic acid-
responsive genes, as well as skin levels of retinol and retinoic acid,
were remarkably elevated. These results support a novel and
important role for skin MUFA synthesis in maintaining cellular
retinol homeostasis and suggest that the origin of the skin
phenotype in SKO mice is due to severe retinoic acid-induced
sebaceous gland hypoplasia.
Results
Thermoneutral environment does not rescue obesity
resistance
We previously reported that SKO mice recapitulate the
hypermetabolic phenotype observed in mice with a whole-body
deletion of SCD1, resulting in resistance to high-fat diet-induced
obesity when housed at ambient temperature (21uC) [7]. To
investigate whether loss of heat to the environment contributes to
the obesity protection, we repeated the diet-induced obesity
experiment in SKO mice at thermoneutral temperature (32.5–
33.5uC). Mice were fed a high-fat diet (60% kcal fat; Harlan
TD.06414) for 7 weeks at this temperature. Surprisingly, the
obesity resistance phenotype and hyperphagia persisted even at
the elevated temperature (Figure 1), similar to our previous
observations in high-fat fed SKO housed at ambient temperature
[7].
Microarray analysis of skin of SKO mice
To explore mechanisms other than heat loss that may be
responsible for the skin-derived alteration in whole-body energy
metabolism in SKO mice, we analyzed skin gene expression in 8–9
week old male SKO mice (n=3) and Scd1
flox/flox (Lox) control mice
(n=3) using Affymetrix 430 2.0 microarrays. The summary of the
number of probe sets found to be differentially expressed by either
EBarrays or Welch’s t-test are shown in Table 1. Applying
EBarrays with the posterior probability of differential expression
(DE) set at 0.639 (soft 5% false discovery rate (FDR) cutoff) or 0.95
(hard 5% FDR cutoff) yielded 8648 and 6433 DE probe sets,
respectively. The Welch’s t-test yielded 969 DE probe sets with q-
values less than 0.05. When comparing the two approaches, 897 of
those 969 probe sets identified as DE via t-tests are also identified
as DE by EBarrays (posterior probability of DE .0.95). The set of
transcripts differentially expressed between Lox and SKO is
enriched for 16 gene ontology (GO) terms, which are listed in
Table 2.
Sebaceous gland hypoplasia, epidermal hyperplasia and
inflammation
Studies by Sundberg et al. in the naturally occurring Scd1
ab-2j
mutant have suggested that SCD1 is required for a functional
sebaceous gland and for the degradation of the inner root sheath
from the emerging hair shaft [8]. Thus, MUFA production by the
sebaceous gland is critical for sebocyte maintenance and function.
Consistent with the previous histological observation of sebaceous
gland hypoplasia [19,20], we observed decreased expression in
SKO skin of two key markers of terminal sebocyte differentiation,
Scd3 and Mc5R (Table 3). The expression of the cytochrome P450
1A1 (Cyp1a1), which encodes a xenobiotic metabolizing enzyme
expressed in the sebaceous gland [21], was also largely ablated
(Table 3). Additionally, the expression of androgen receptor (Ar),
which is enriched in the basal layer of the sebaceous gland and in
Figure 1. SKO mice remain resistant to obesity in a thermo-
neutral environment. Male Lox and SKO mice (n=9–10) were
transferred at 6 weeks of age to a controlled environment (32.5–33.5uC;
30–40% relative humidity), allowed to acclimate for 2 weeks and then
fed a high-fat diet (Harlan TD.06414; 60% kcal fat) for 7 weeks. A) Body
weight curve; B) Food intake. Data represent mean 6 SEM. *, p,0.05.
doi:10.1371/journal.pone.0019734.g001
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dramatically suppressed in skin of SKO mice (Table 3).
The impaired degradation of the inner root sheath due to Scd1
deficiency-related sebaceous gland dysfunction is hypothesized to
cause restraint and destruction of the hair follicle, inducing an
inflammatory reaction, epidermal hyperplasia and scarring
alopecia [8]. Consistent with these observations, we observed
increased expression of several transcripts supporting prominent
keratinocyte activation and differentiation including keratin 6, 16
and 17 (Krt6a, Krt6b, Krt16, Krt17), involucrin (Ivl), filaggrin (Flg),
transglutaminase 1 (Tgm1), and several genes encoding members of
the small proline-rich and late cornified envelope protein family
(Table 4).
The skin phenotype due to Scd1 deficiency is consistent with
atopic dermatitis, involving inflammation and pruritis. Although
this often culminates in spontaneous ulcerative dermatisis in older
mice (unpublished observations), none of the mice used in the
current study displayed this condition. Skin inflammation is
evident from the increased expression of a large number of
chemokine ligands, chemokine receptors and other mediators of
the inflammatory process including transforming growth factor
beta (Tgfb1), tumor necrosis factor (Tnf), several members of the
NF-kb pathway and others listed in Table 5 and Table S1.
Several members of the interleukin family of cytokines were
elevated including interleukin (IL)-1b (Il1b), IL-18 (Il18), IL-33
(Il33), and IL1-family members 5, 6, 8 and 9 (Il1f5, Il1f6, Il1f8,
Il1f9). We also observed a modest increase in the expression level
of the receptors for IL-1 and IL-18 (Il1r1 and Il18r1), and the IL-1
accessory protein (Il1rap). Activation of the IL-1 pathway may be
further influenced by the observed increase in expression of the
IL-1 receptor antagonist (Il1rn) and decrease in the expression of
the IL-1 decoy receptor Il1r2, which decreases the activity of the
ligands for the active IL-1 receptor Il1r1. Notably, we observed a
large increase in Cd44, which increases with inflammation and
modulates epidermal proliferation and inflammatory responses
[23]. Inflammation can also be influenced by fatty acid products of
lipoxygenases. We observed ,2-fold decrease in the expression of
platelet-type 12-lipoxygenase (Alox12), which has previously been
shown to be important for a normal permeability barrier [24], as
well as decreased expression of 5-lipoxygenase Alox5 (Table S2).
However, expression of the epidermal-type 12-lipoxygenase
Alox12e and the leukocyte-type 12-lipoxygenase Alox15 were
increased 2.5 to 3-fold.
Increased expression of genes encoding antimicrobial peptides
of the defensin family (Defb1, Defb3, Defb4 and Defb6) [25], injury-
induced calcium-binding proteins (S100a8 and S100a9) [26] and
the acute phase response proteins serum amyloid A1–A3 (Saa1,
Saa2 and Saa3) are consistent with a response to tissue damage and
inflammation (Table 5 and Table S1). Some genes in this
category were decreased, which may indicate an anti-inflamma-
tory process or an adaptation to prolonged inflammation.
Increased expression of the Jun, Fos and Cebpb transcription
factors suggest activation of the inflammatory and proliferating
phase of the wound healing process (Table 6). Several other
transcriptional changes in SKO mice parallel other models of
wound healing and dermatitis including elevated expression of
tenascin C (Tnc) [27], osteopontin (Spp1) [28], thrombospondin-1
(Thbs1) [29] and Socs3 [30] (Table 7).
Increased tissue remodeling is supported by differential
expression of a wide array of proteolytic genes encoding matrix
metalloproteases, tissue-inhibitors of metalloproteases, cathepsins,
and ADAM (a disintegrin and metalloproteinase) family proteins
(Table S3). The differential expression of several genes encoding
collagens, keratins, gap junction proteins, tight junction proteins
and cadherins suggest rampant changes in keratinization,
extracellular matrix composition and cell adhesion (Table S4).
Of note, we observed a 38-fold increase in Gjb2 (gap junction
protein, beta 2; connexin-26), whose over-expression has been
reported to keep epidermis in a hyperproliferative state, block the
transistion to remodeling, lead to immune cell infiltration and
delay epidermal barrier recovery [31]. Additionally, we observed
increased expression of early growth response-1 (Egr1), which is
important for TGF-b-dependent matrix remodeling [32]
(Table 6).
Imbalance of fatty acid and sterol synthesis
A proper balance of stratum corneum lipids is required for
maintenance of normal barrier function. For example, mice
topically treated with the sterol synthesis inhibitor lovastatin have
decreased epidermal sterol synthesis but increased fatty acid
synthesis coincident with the development of an impaired
Table 2. Enriched Gene Ontology (GO) Terms.
Myofibril Contractile Fiber Sacromere Contractile Fiber Part
Actin Binding Actin Cytoskeleton Cytoskeletal Protein Binding I Band
Anatomical Structure Formation Involved in Morphogenesis Z Disc Cell-cell Junction Ectoderm Development
Epidermis Development Skeletal System Development Apicolateral Plasma Membrane Muscle System Process
Tests of enrichment of GO terms via overrepresentation were conducted on the set of 8648 differentially expressed probe sets identified by EBarrays. The tests were
performed using the allez R package. GO terms were said to be overrepresented if they had at least 5 distinct probe sets in the differentially expressed list being
analyzed, but no more than 500, and surpassed a Z-score cutoff of 5. GO terms are listed in left-to-right and top-to-bottom decreasing order of significance. The same
set of criteria was used to assess enrichment using KEGG pathways, but no such pathway was found for this dataset.
doi:10.1371/journal.pone.0019734.t002
Table 1. Summary of Differentially Expressed Probe Sets
(DEPS).
Method
Total
DEPS Increased Decreased
EBarrays (soft); 5% FDR PP of DE.0.639 8648 4558(1495) 4090(1313)
EBarrays (hard); 5% FDR PP of DE.0.95 6433 3415(1469) 3018(1276)
Welch’s t-test (q,0.05) 969 550(377) 419(236)
Welch’s t-test AND EBarrays Intersect 897 516(377) 381(236)
Affymetrix Mouse 430 2.0 microarray chips were used to search for skin gene
expression changes between male Lox and SKO mice. Lists of differentially
expressed probe sets (DEPS) were generated using Welch’s t-tests or EBarrays,
as described in Methods. For each comparison, the number of total, increased
and decreased DEPS is shown, and those with a fold-change of 2-fold or more
are indicated in parentheses.
doi:10.1371/journal.pone.0019734.t001
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hepatic Scd1 deficiency blocks the dietary carbohydrate-induction
of fatty acid synthesis and triglyceride accumulation [34].
Consistent with this pattern, the skin of SKO mice displayed
decreased expression of mRNAs encoding key fatty acid synthesis
enzymes including fatty acid synthase (Fasn), stearoyl-CoA
desaturases-1 and -3 (Scd1 and Scd3), elongases (Elovl1, Elovl3,
Elovl5 and Elovl6) and SPOT14 (Thrsp), and triglyceride synthesis
enzymes including Gpam, Lpin1, Agpats (-2,- 4, and -5) and Dgat1
(Tables 8 and 9). In contrast, we observed increased mRNA
expression for the D9- and D6-desaturases Scd2 and Fads2,
respectively, along with the elongase Elovl7, which preferentially
Table 3. Sebaceous gland or sebocyte markers.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1460723_at Mc5r melanocortin 5 receptor 0.59 0.99 0.111
1437064_at Ar androgen receptor 0.31 1.00 0.153
1455647_at Ar androgen receptor 0.22 1.00 0.107
1422217_a_at Cyp1a1 cytochrome P450, family 1,
subfamily a, polypeptide 1
0.19 1.00 0.023
1450956_at Scd3 stearoyl-CoA desaturase 3 0.09 1.00 0.052
1423366_at Scd3 stearoyl-CoA desaturase 3 0.08 1.00 0.053
Changes in gene expression are reported as fold-change (FC) relative to Lox mice. Significant differences between Lox and SKO were determined as described in
Methods, and for both Welch’s t-test and EBarrays the false discovery rate was set at 5%. All probe sets listed have a posterior probability of differential expression (PP of
DE) .0.639 (soft threshold) based upon analysis by EBarrays. Additionally, Welch’s t-test was used to calculate q-values and those probe sets with q-values,0.05 were
considered significant.
doi:10.1371/journal.pone.0019734.t003
Table 4. Keratinocyte differentiation and activation; epidermal barrier formation.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1422672_at Sprr1b small proline-rich protein 1B 29.95 1.00 0.114
1456248_at Lce3f late cornified envelope 3F 20.40 1.00 0.083
1422240_s_at Sprr2h small proline-rich protein 2H 17.52 1.00 0.075
1448932_at Krt16 keratin 16 16.26 1.00 0.101
1439016_x_at Sprr2a small proline-rich protein 2A 12.27 1.00 0.044
1450618_a_at Sprr2a small proline-rich protein 2A 11.67 1.00 0.045
1422588_at Krt6b keratin 6B 11.01 1.00 0.165
1422783_a_at Krt6a keratin 6A 10.57 1.00 0.023
1449133_at Sprr1a small proline-rich protein 1A 7.82 1.00 0.04
1427700_x_at Krt6a keratin 6A 7.35 1.00 0.037
1420771_at Sprr2d small proline-rich protein 2D 7.20 0.99 0.172
1420193_at Krt17 keratin 17 6.62 1.00 0.037
1456001_at Lce3a late cornified envelope 3A 6.51 1.00 0.157
1422963_at Sprr2i small proline-rich protein 2I 6.42 0.87 0.225
1422784_at Krt6a keratin 6A 5.34 1.00 0.019
1419317_x_at Lce3c late cornified envelope 3C 4.81 1.00 0.156
1427268_at Flg Filaggrin 4.68 1.00 0.072
1421316_at Lce1g late cornified envelope 1G 4.63 1.00 0.1
1429540_at Cnfn Cornifelin 2.93 1.00 0.066
1423227_at Krt17 keratin 17 2.88 1.00 0.03
1451416_a_at Tgm1 Transglutaminase 1, K polypeptide 2.58 1.00 0.073
1439878_at Ivl Involucrin 2.50 1.00 0.107
1422222_at Ivl Involucrin 1.87 1.00 0.1
1420550_at Lce1f late cornified envelope 1F 1.84 1.00 0.052
1418855_at Lce1l late cornified envelope 1L 0.66 0.94 0.132
1429565_s_at Lce1m late cornified envelope 1M 0.33 1.00 0.042
See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t004
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AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1438148_at Cxcl3 chemokine (C-X-C motif) ligand 3 30.63 1.00 0.11
1450826_a_at Saa3 serum amyloid A 3 25.47 1.00 0.055
1449984_at Cxcl2 chemokine (C-X-C motif) ligand 2 22.85 1.00 0.075
1448377_at Slpi secretory leukocyte peptidase inhibitor 21.69 1.00 0.057
1448756_at S100a9 S100 calcium binding protein A9 (calgranulin B) 20.77 1.00 0.058
1450788_at Saa1 serum amyloid A 1 14.12 1.00 0.055
1419394_s_at S100a8 S100 calcium binding protein A8 (calgranulin A) 11.98 1.00 0.055
1419728_at Cxcl5 chemokine (C-X-C motif) ligand 5 8.98 1.00 0.102
1418609_at Il1f6 interleukin 1 family, member 6 7.85 1.00 0.082
1419209_at Cxcl1 chemokine (C-X-C motif) ligand 1 7.71 1.00 0.089
1421688_a_at Ccl1 chemokine (C-C motif) ligand 1 6.36 1.00 0.061
1419492_s_at Defb1 defensin beta 1 5.40 1.00 0.06
1422029_at Ccl20 chemokine (C-C motif) ligand 20 5.00 1.00 0.089
1419491_at Defb1 defensin beta 1 4.68 1.00 0.062
1419600_at Defb4 defensin beta 4 4.66 1.00 0.053
1426300_at Alcam activated leukocyte cell adhesion molecule 4.35 1.00 0.044
1419561_at Ccl3 chemokine (C-C motif) ligand 3 4.10 1.00 0.122
1417932_at Il18 interleukin 18 4.04 1.00 0.039
1421806_at Defb3 defensin beta 3 3.97 1.00 0.031
1449399_a_at Il1b interleukin 1 beta 3.89 1.00 0.082
1434376_at Cd44 CD44 antigen 3.73 1.00 0.06
1452483_a_at Cd44 CD44 antigen 3.68 1.00 0.071
1423760_at Cd44 CD44 antigen 3.65 1.00 0.099
1448823_at Cxcl12 chemokine (C-X-C motif) ligand 12 3.48 1.00 0.068
1417925_at Ccl22 chemokine (C-C motif) ligand 22 3.28 1.00 0.052
1437467_at Alcam activated leukocyte cell adhesion molecule 3.26 1.00 0.058
1417574_at Cxcl12 chemokine (C-X-C motif) ligand 12 3.20 1.00 0.039
1418457_at Cxcl14 chemokine (C-X-C motif) ligand 14 3.11 1.00 0.113
1449195_s_at Cxcl16 chemokine (C-X-C motif) ligand 16 2.99 1.00 0.062
1417483_at Nfkbiz nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor, zeta
2.87 1.00 0.082
1437466_at Alcam activated leukocyte cell adhesion molecule 2.84 1.00 0.04
1418718_at Cxcl16 chemokine (C-X-C motif) ligand 16 2.78 1.00 0.067
1451798_at Il1rn interleukin 1 receptor antagonist 2.77 1.00 0.051
1426301_at Alcam activated leukocyte cell adhesion molecule 2.74 1.00 0.073
1423466_at Ccr7 chemokine (C-C motif) receptor 7 2.72 1.00 0.069
1448710_at Cxcr4 chemokine (C-X-C motif) receptor 4 2.69 1.00 0.129
1419609_at Ccr1 chemokine (C-C motif) receptor 1 2.58 0.99 0.175
1418456_a_at Cxcl14 chemokine (C-X-C motif) ligand 14 2.48 1.00 0.054
1421807_at Defb6 defensin beta 6 2.41 1.00 0.071
1425715_at Il1f8 interleukin 1 family, member 8 2.34 1.00 0.148
1433699_at Tnfaip3 tumor necrosis factor, alpha-induced protein 3 2.28 1.00 0.037
1457644_s_at Cxcl1 chemokine (C-X-C motif) ligand 1 2.21 1.00 0.104
1418424_at Tnfaip6 tumor necrosis factor alpha induced protein 6 2.19 1.00 0.127
1419413_at Ccl17 chemokine (C-C motif) ligand 17 2.16 1.00 0.077
1425663_at Il1rn interleukin 1 receptor antagonist 2.12 1.00 0.095
1421370_a_at Il1f5 interleukin 1 family, member 5 (delta) 2.04 1.00 0.109
See Table S1 for additional probe sets. See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t005
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phosphatase Lpin2. Additionally, we observed decreased expres-
sion of several lipases including the triglyceride/diacylglyceride
lipase Pnpla2 (Atgl), diacylglyceride lipases Dagla and Daglb and the
monoglyceride lipase Mgll, which is indicative of decreased hy-
drolysis of acylglycerol stores to free fatty acids and glycerol.
As opposed to decreased fatty acid synthesis, key choles-
terol synthesis genes such as HMG-CoA synthase-1 (Hmgcs1),
HMG-CoA reductase (Hmgcr), 3-b-hydroxysterol-D24 reductase
(Dhcr24), sterol-C5-desaturase (Sc5d) and squalene epoxidase (Sqle)
were increased, while mevalonate decarboxylase (Mvd) was
decreased (Table 10). The expression of the cholesterol sulfo-
transferase Sult2b1, which increases with keratinocyte differentiation
and whose cholesterol sulfate product inhibits serine protease
activity to prevent corneodesmosome degradation, was increased in
SKO mice [36]. Overall, this gene expression pattern suggests that
skin lipid synthesis is imbalanced in SKO mice, characterized by
increased sterol synthesis and decreased fatty acid synthesis.
Besides fatty acids and cholesterol, sphingolipids are important
skin lipids for barrier acquisition. All three serine palmitoyltrans-
Table 6. Transcription factors and co-activators.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1417065_at Egr1 early growth response 1 4.95 1.00 0.031
1418175_at Vdr vitamin D receptor 3.68 1.00 0.032
1418176_at Vdr vitamin D receptor 3.10 1.00 0.057
1417981_at Insig2 insulin induced gene 2 3.09 1.00 0.066
1417982_at Insig2 insulin induced gene 2 3.07 1.00 0.048
1417980_a_at Insig2 insulin induced gene 2 2.90 1.00 0.074
1423100_at Fos FBJ osteosarcoma oncogene 2.88 1.00 0.058
1435950_at Hr Hairless 2.25 1.00 0.019
1427844_a_at Cebpb CCAAT/enhancer binding protein (C/EBP), beta 2.24 1.00 0.082
1449945_at Ppargc1b peroxisome proliferative activated receptor, gamma, coactivator 1 beta 2.07 1.00 0.116
1417409_at Jun Jun oncogene 2.07 1.00 0.103
1448694_at Jun Jun oncogene 2.04 1.00 0.041
1422110_at Hr Hairless 1.92 1.00 0.097
1439797_at Ppard peroxisome proliferator activator receptor delta 1.89 1.00 0.07
1418901_at Cebpb CCAAT/enhancer binding protein (C/EBP), beta 1.67 1.00 0.036
1422631_at Ahr aryl-hydrocarbon receptor 1.65 0.82 0.18
1417395_at Klf4 Kruppel-like factor 4 (gut) 1.47 0.96 0.078
1438796_at Nr4a3 nuclear receptor 4a3 1.46 0.98 0.092
1457721_at Ppara peroxisome proliferator activated receptor alpha 0.72 0.94 0.13
1420715_a_at Pparg peroxisome proliferator activated receptor gamma 0.70 0.98 0.094
1437751_at Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha 0.70 0.83 0.152
1448886_at Gata3 GATA binding protein 3 0.68 0.99 0.074
1436325_at Rora RAR-related orphan receptor alpha 0.59 0.82 0.184
1426997_at Thra thyroid hormone receptor alpha 0.58 1.00 0.065
1416505_at Nr4a1 nuclear receptor subfamily 4a1 0.56 0.91 0.163
1456395_at Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha 0.56 1.00 0.082
1454734_at Lef1 lymphoid enhancer binding factor 1 0.56 1.00 0.101
1426690_a_at Srebf1 sterol regulatory element binding transcription factor 1 0.53 1.00 0.056
1454671_at Insig1 insulin induced gene 1 0.51 0.96 0.159
1434099_at Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha 0.51 1.00 0.141
1426464_at Nr1d1 nuclear receptor subfamily 1d1 0.51 1.00 0.051
1450444_a_at Nr1h3 nuclear receptor subfamily 1h3 0.51 1.00 0.132
1434100_x_at Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha 0.47 1.00 0.152
1425792_a_at Rorc RAR-related orphan receptor gamma 0.45 1.00 0.058
1454675_at Thra thyroid hormone receptor alpha 0.44 1.00 0.054
1439675_at Ppara peroxisome proliferator activated receptor alpha 0.44 1.00 0.039
1457635_s_at Nr3c1 nuclear receptor subfamily 3c1 0.41 1.00 0.114
1418782_at Rxrg Retinoid X receptor gamma 0.38 1.00 0.069
1419185_a_at Mlxipl MLX interacting protein-like 0.30 1.00 0.056
See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t006
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sphingosine formation for ceramide synthesis (Table 11). We
observed decreased expression of the sphingosine kinase (Sphk2)
and increased expression of two sphingosine-1-phosphate phos-
phatases (Sgpp1 and Sgpp2) as well as sphignosine phosphate lyase 1
(Sgpl1), suggestive of decreased levels of sphingosine-1-phosphate.
Additionally, we observed decreased expression of the ceramide
synthases Lass4 and Lass5 but increased expression of the
dihydroceramide desaturases Degs1 and Degs2. Most epidermal
fatty acyl residues in ceramides are $C28 chain lenth and skin
expresses five different ceramide synthase genes with different fatty
acyl-CoA chain length preferences; however, it is currently not
Table 7. Increased in wounded and inflammed skin, psoriasis.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1416342_at Tnc Tenascin C 26.95 1.00 0.05
1449254_at Spp1 secreted phosphoprotein 1 24.88 1.00 0.041
1460302_at Thbs1 thrombospondin 1 11.57 1.00 0.019
1418350_at Hbegf Heparin-binding EGF-like growth factor 10.39 1.00 0.08
1418349_at Hbegf Heparin-binding EGF-like growth factor 9.59 1.00 0.037
1421943_at Tgfa Transforming growth factor alpha 2.92 1.00 0.053
1450271_at Ptk6 PTK6 protein tyrosine kinase 6 2.37 1.00 0.123
1455899_x_at Socs3 suppressor of cytokine signaling 3 2.03 1.00 0.07
1416576_at Socs3 suppressor of cytokine signaling 3 1.93 1.00 0.086
1456212_x_at Socs3 suppressor of cytokine signaling 3 1.92 1.00 0.084
1442923_at Ptk6 PTK6 protein tyrosine kinase 6 1.79 0.96 0.158
See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t007
Table 8. Fatty acid synthesis, elongation and desaturation.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1418773_at Fads3 fatty acid desaturase 3 3.12 1.00 0.055
1449219_at Fads3 fatty acid desaturase 3 3.09 1.00 0.064
1435910_at Fads3 fatty acid desaturase 3 2.98 1.00 0.07
1424097_at Elovl7 ELOVL family member 7, elongation of long chain fatty acids (yeast) 2.64 1.00 0.096
1415823_at Scd2 stearoyl-Coenzyme A desaturase 2 2.51 1.00 0.066
1440312_at Elovl7 ELOVL family member 7, elongation of long chain fatty acids (yeast) 1.78 1.00 0.089
1441091_at Elovl7 ELOVL family member 7, elongation of long chain fatty acids (yeast) 1.71 0.87 0.194
1419031_at Fads2 fatty acid desaturase 2 1.46 0.82 0.152
1415822_at Scd2 stearoyl-Coenzyme A desaturase 2 1.40 0.86 0.078
1436355_at Fads6 fatty acid desaturase domain family, member 6 0.69 0.86 0.152
1443820_x_at Elovl1 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1 0.51 1.00 0.105
1415964_at Scd1 stearoyl-Coenzyme A desaturase 1 0.47 0.81 0.141
1443904_at Fads6 fatty acid desaturase domain family, member 6 0.42 1.00 0.047
1420722_at Elovl3 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 0.39 1.00 0.069
1423828_at Fasn fatty acid synthase 0.38 1.00 0.071
1417404_at Elovl6 ELOVL family member 6, elongation of long chain fatty acids (yeast) 0.32 1.00 0.095
1415965_at Scd1 stearoyl-Coenzyme A desaturase 1 0.25 1.00 0.1
1415840_at Elovl5 ELOVL family member 5, elongation of long chain fatty acids (yeast) 0.20 1.00 0.12
1437211_x_at Elovl5 ELOVL family member 5, elongation of long chain fatty acids (yeast) 0.19 1.00 0.087
1424737_at Thrsp thyroid hormone responsive SPOT14 homolog (Rattus) 0.16 1.00 0.083
1422973_a_at Thrsp thyroid hormone responsive SPOT14 homolog (Rattus) 0.14 1.00 0.092
1450956_at Scd3 stearoyl-CoA desaturase 3 0.09 1.00 0.052
1423366_at Scd3 stearoyl-Coenzyme A desaturase 3 0.08 1.00 0.053
See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t008
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acylation of ceramide [37]. Glucosylceramide synthase (Ugcg),
whose product glucosylceramides are the dominant epidermal
glycosphingolipids and required for epidermal barrier function,
was increased [38]. However, the expression of the fatty acid 2-
hydroxylase Fa2h was decreased, indicative of decreased 2-OH
ceramide and 2-OH glucosylceramide formation [39]. Addition-
ally, we observed increased expression of sphingomyelin synthase
2( Sgms2) and decreased expression of sphingomyelin phosphodi-
esterase 1 (Smpd1), suggesting increased utilization of ceramide for
sphingomyelin synthesis. Overall, the sphingolipid and fatty acid
gene expression pattern suggests that the machinery for ceramide
and glucosylceramide is intact or upregulated, but that the
composition of the fatty acyl chains is greatly altered.
Altered abundance of key metabolic transcription factors
The suppression of fatty acid synthesis may possibly be
explained by the dramatic downregulation of several transcription
factors involved in lipid metabolism (Table 6). We observed
decreased expression of SREBP-1 (Srebf1), LXR-a (Nr1h3),
ChREBP (Mlxipl), peroxisome proliferators activated receptor
(PPAR) a and c (Ppara and Pparg). Additionally, elevated ex-
pression of Insig2 suggests a decrease in the maturation of SREBP-
1( Table 6). Despite the increased expression of several genes
involved in cholesterol synthesis, the expression of Srebp2 was not
different. We also observed increased expression of PPARd (Ppard)
and PPARc-coactivator 1b (Ppargc1b)( Table 6). This expression
pattern is consistent with human keratinocytes treated with
cytokines and UV light, in which the expression of PPARD is
Table 9. Acyltransferases, fatty acid binding proteins and lipases.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1416022_at Fabp5 fatty acid binding protein 5, epidermal 2.32 1.00 0.093
1452836_at Lpin2 lipin 2 2.25 1.00 0.075
1452837_at Lpin2 lipin 2 1.55 1.00 0.112
1455448_at Dagla diacylglycerol lipase, alpha 0.75 0.68 0.113
1445229_at Dgat1 diacylglycerol O-acyltransferase 1 0.74 0.83 0.095
1431331_at Mgll monoglyceride lipase 0.73 0.87 0.126
1434287_at Agpat5 1-acylglycerol-3-phosphate O-acyltransferase 5
(lysophosphatidic acid acyltransferase, epsilon)
0.69 0.76 0.127
1428336_at Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4
(lysophosphatidic acid acyltransferase, delta)
0.57 1.00 0.052
1419499_at Gpam glycerol-3-phosphate acyltransferase, mitochondrial 0.56 0.97 0.112
1426516_a_at Lpin1 lipin 1 0.56 1.00 0.101
1451970_at Daglb diacylglycerol lipase, beta 0.53 0.93 0.133
1418288_at Lpin1 lipin 1 0.51 1.00 0.069
1436640_x_at Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4
(lysophosphatidic acid acyltransferase, delta)
0.50 1.00 0.096
1428143_a_at Pnpla2 patatin-like phospholipase domain containing 2 0.48 1.00 0.05
1418295_s_at Dgat1 diacylglycerol O-acyltransferase 1 0.47 1.00 0.107
1426785_s_at Mgll monoglyceride lipase 0.44 1.00 0.072
1450391_a_at Mgll monoglyceride lipase 0.43 1.00 0.067
1428821_at Agpat2 1-acylglycerol-3-phosphate O-acyltransferase 2
(lysophosphatidic acid acyltransferase, beta)
0.36 1.00 0.117
1416023_at Fabp3 fatty acid binding protein 3, muscle and heart 0.19 1.00 0.043
See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t009
Table 10. Cholesterol synthesis.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1415993_at Sqle squalene epoxidase 2.38 1.00 0.083
1451457_at Sc5d sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) 2.33 1.00 0.061
1427229_at Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase 2.18 1.00 0.094
1418129_at Dhcr24 24-dehydrocholesterol reductase 2.15 1.00 0.105
1417335_at Sult2b1 sulfotransferase family, cytosolic, 2B, member 1 1.93 1.00 0.099
1433446_at Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 1.81 1.00 0.102
1448663_s_at Mvd mevalonate (diphospho) decarboxylase 0.57 0.97 0.115
See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t010
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decreased [40]. In lesional skin of patients with psoriasis and atopic
dermatitis the expression of PPARD was also increased while the
expression of PPARA and PPARG was decreased [40,41]. Although
Ppara and one of its co-activators Ppargc1a were decreased in skin of
SKO mice, we also observed increased expression of the fatty acid
oxidation genes Cpt1a, Acox1 and Crot, potentially due to the
elevated expression of Ppard (Table 6 and Table S2).
Several transcription factors important for skin development were
also differentially expressed (Table 6). The expression of Kruppel-
like factor 4 (Klf4), which is highly expressed in the differentiating
layers of epidermis and is essential for barrier acquisition [42], is
increased in SKO mice. Additionally, we observed decreased
expression of Gata3 and Lef1, which are important transcription
factors involved in hair follicle and inner root sheath skin cell lineage
[43].Interestingly, expression of thevitamin D receptor(Vdr) and the
nuclear receptor co-repressor hairless (Hr) were highly elevated in
SKO mice. Hairless binds VDR to cause transcriptional repression
[44,45]. Overexpression of hairless in skin has been shown to cause
delayed sebaceous gland differentiation, and an increased number of
undifferentiated but decreased number of terminally differentiated
keratinocytes [44,46]. Several other metabolic transcription factors
were also differentially expressed between Lox and SKO mice and
are listed in Table 6.
Accumulation of retinol and retinoic acid and activation
of retinoic acid receptor (RAR)-target genes
One of the major metabolic pathways affected by the absence of
skin SCD1 is retinol metabolism (Table 12). The genes encoding
cellular retinol-binding protein-1 (Rbp1) and cellular retinoic acid-
binding protein-2 (Crabp2) were elevated 8.6- and 6.2-fold,
respectively, consistent with transactivation of RAR. Additionally,
the RAR-target gene lecithin:retinol acyltransferase (Lrat), which
catalyzes the synthesis of retinyl esters from free retinol, was
elevated 3.9-fold. Consistent with increased Lrat expression, levels
of retinyl esters were 2.4-fold elevated in skin of SKO mice
(Figure 2B). Skin has also been shown to possess physiologically
significant acyl-CoA:retinol acyltransferase (ARAT) activity due to
acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) and possibly
other acyltransferases [47,48]. Levels of Dgat1 mRNA were
decreased in the skin of SKO mice, consistent with a reduced
synthesis of ARAT-derived retinyl esters (Table 9).
Elevation of RAR target gene expression in skin is consistent
with increased levels of retinoic acid in the skin. Indeed, the
levels of all-trans retinol and all-trans retinoic acid were elevated
in SKO skin 2.3-fold and 1.9-fold, respectively (Figure 2A).
Plasma levels of all-trans retinol (Figure 2C), as well as retinyl
e s t e rs t o r e si nt h el i v e r( Figure 2D) and epididymal white
adipose (data not shown) were not significantly different between
Lox and SKO mice.
Retinol is oxidized to retinaldehyde by cytosolic alcohol dehy-
drogenases (ADH) of the medium-chain dehydrogenase/reductase
family and microsomal retinol dehydrogenases (RDH) of the short-
chain dehydrogenase/reductase family [49]. We observed de-
creased expression of Adh1 (class I), Adh7 (Class 4), Adh6a and
Adh6b (class V), as well as decreased expression of Rdh1, Rdh5 and
Rdh9, but increased expression of Rdh10 and Rdh12 (Table 12).
Retinaldehyde is converted to retinoic acid via the action of
retinaldehyde dehydrogenases encoded by Aldh1a1–Aldh1a3. The
Table 11. Sphingolipid synthesis.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1424549_at Degs2 degenerative spermatocyte homolog 2 (Drosophila), lipid desaturase 13.53 1.00 0.053
1457867_at Sgpp2 sphingosine-1-phosphate phosphotase 2 7.35 1.00 0.042
1415893_at Sgpl1 sphingosine phosphate lyase 1 2.51 1.00 0.042
1421268_at Ugcg UDP-glucose ceramide glucosyltransferase 2.41 1.00 0.055
1421269_at Ugcg UDP-glucose ceramide glucosyltransferase 2.41 1.00 0.087
1435133_at Ugcg UDP-glucose ceramide glucosyltransferase 2.23 1.00 0.066
1422690_at Sptlc1 serine palmitoyltransferase, long chain base subunit 1 2.03 1.00 0.052
1450015_x_at Sgpp1 sphingosine-1-phosphate phosphatase 1 1.89 0.99 0.154
1436726_s_at Sptlc1 serine palmitoyltransferase, long chain base subunit 1 1.80 1.00 0.065
1423345_at Degs1 degenerative spermatocyte homolog 1 (Drosophila) 1.77 1.00 0.067
1415892_at Sgpl1 sphingosine phosphate lyase 1 1.64 1.00 0.023
1429029_at Sgms2 sphingomyelin synthase 2 1.63 1.00 0.044
1460243_at Sptlc2 serine palmitoyltransferase, long chain base subunit 2 1.48 1.00 0.058
1439492_at Sptlc3 serine palmitoyltransferase, long chain base subunit 3 1.42 0.93 0.091
1447874_x_at Smpd1 sphingomyelin phosphodiesterase 1, acid lysosomal 0.67 1.00 0.082
1448621_a_at Smpd1 sphingomyelin phosphodiesterase 1, acid lysosomal 0.62 1.00 0.07
1426230_at Sphk2 sphingosine kinase 2 0.61 1.00 0.04
1447308_at Lass5 LAG1 homolog, ceramide synthase 5 0.45 1.00 0.114
1451209_at Lass5 LAG1 homolog, ceramide synthase 5 0.37 1.00 0.091
1417781_at Lass4 LAG1 homolog, ceramide synthase 4 0.36 1.00 0.047
1417780_at Lass4 LAG1 homolog, ceramide synthase 4 0.31 1.00 0.089
1426960_a_at Fa2h fatty acid 2-hydroxylase 0.24 1.00 0.052
See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t011
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Aldh1a3 were elevated, whereas the expression of Aldh1a1 was
decreased (Table 12). We also observed 2.8-fold increase
expression of Stra6, which encodes the membrane receptor for
the circulating retinol binding protein [50]. A decreased capacity
for retinoic acid catabolism may also contribute to the elevated
levels of skin retinoic acid. We observed a robust decrease in the
expression of Cyp1a1 and Cyp2e1, but increased expression of
Cyp1b1, all of which are expressed in murine skin and encode
enzymes with reported retinoic acid 4-hydroxylase activity
(Table 12) [51,52].
To help determine whether the disturbed retinol metabolism is
responsible for the skin phenotypes in Scd1 S K Om i c e ,w e
subjected Lox and SKO mice to a retinoid-deficient (RD) diet
intervention. In both Lox and SKO mice, this RD diet
intervention dramatically reduced hepatic retinol and retinyl ester
stores to less than 0.25% of the hepatic stores observed in mice fed
the standard diet (Figure 2D), but in comparison only modestly
reduced plasma retinol levels in both Lox and SKO mice
(Figure 2C). However, skin all-trans retinoic acid levels remained
1.5-fold elevated in SKO mice compared to Lox mice (p,0.05;
data not shown). Gross and histological examination of skin
indicated that the RD diet elicited no remarkable improvement in
the phenotype observed in standard diet-fed SKO mice (data not
shown). This highlights that SCD1 is critical for skin retinoid
homeostasis even under conditions of reduced retinol availability.
Retinoic acid transactivation of PPARd
Retinoic acid can bind to both CRABP2 and FABP5, which
then delivers the ligand to transactivate RAR and PPARd,
Table 12. Retinol metabolism.
AFFY ID Gene Symbol Gene Name FC PP of DE q-value
1427747_a_at Lcn2 lipocalin 2 27.69 1.00 0.043
1448754_at Rbp1 retinol binding protein 1, cellular 8.62 1.00 0.019
1451191_at Crabp2 cellular retinoic acid binding protein II 6.20 1.00 0.029
1416612_at Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 4.97 1.00 0.056
1444487_at Lrat lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) 3.87 1.00 0.072
1422789_at Aldh1a2 aldehyde dehydrogenase family 1, subfamily A2 3.86 1.00 0.116
1426968_a_at Rdh10 retinol dehydrogenase 10 (all-trans) 3.70 1.00 0.053
1416613_at Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 3.04 1.00 0.053
1422723_at Stra6 stimulated by retinoic acid gene 6 2.79 1.00 0.113
1417400_at Rai14 retinoic acid induced 14 2.58 1.00 0.079
1448789_at Aldh1a3 aldehyde dehydrogenase family 1, subfamily A3 2.48 0.99 0.176
1431010_a_at Rdh12 retinol dehydrogenase 12 2.38 0.92 0.189
1417401_at Rai14 retinoic acid induced 14 2.24 1.00 0.088
1424256_at Rdh12 retinol dehydrogenase 12 2.09 1.00 0.059
1441030_at Rai14 retinoic acid induced 14 2.02 1.00 0.111
1427395_a_at Aldh1a3 aldehyde dehydrogenase family 1, subfamily A3 1.82 1.00 0.076
1422846_at Rbp2 retinol binding protein 2, cellular 1.62 1.00 0.093
1417642_at Aldh1a3 aldehyde dehydrogenase family 1, subfamily A3 1.57 0.97 0.115
1444777_at Rai14 retinoic acid induced 14 1.50 1.00 0.053
1424715_at Retsat retinol saturase (all trans retinol 13,14 reductase) 0.66 0.65 0.154
1418808_at Rdh5 retinol dehydrogenase 5 0.65 1.00 0.083
1427963_s_at Rdh9 retinol dehydrogenase 9 0.58 1.00 0.062
1448326_a_at Crabp1 cellular retinoic acid binding protein I 0.58 0.94 0.131
1450110_at Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide 0.57 1.00 0.039
1449461_at Rbp7 retinol binding protein 7, cellular 0.56 1.00 0.09
1452358_at Rai2 retinoic acid induced 2 0.52 1.00 0.061
1441094_at Adh6b alcohol dehydrogenase 6B (class V) 0.45 1.00 0.055
1421702_at Rdh1 retinol dehydrogenase 1 (all trans) 0.43 1.00 0.091
1426225_at Rbp4 retinol binding protein 4, plasma 0.42 1.00 0.07
1416225_at Adh1 alcohol dehydrogenase 1 (class I) 0.27 1.00 0.072
1422217_a_at Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 0.19 1.00 0.023
1415994_at Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 0.16 1.00 0.094
1416468_at Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 0.14 1.00 0.089
1429608_at Adh6a alcohol dehydrogenase 6A (class V) 0.09 1.00 0.019
See Table 3 for legend.
doi:10.1371/journal.pone.0019734.t012
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important determinant of the relative transactivation of RAR and
PPARd [53,54]. In addition to the aforementioned increased
expression of Ppard and Crabp2 in SKO mice, we observed elevated
Fabp5 (Table 9), which combined with increased retinoic
acid availability may lead to increased PPARd transactivation.
PPARdhas been shown to contribute to the expression of Lrat and
Rbp1 in activated hepatic stellate cells and may also influence the
expression of retinoid metabolism genes in the skin [55].
Interestingly, transgenic mice that overexpress PPARd develop a
psoriasis-like inflammatory skin disease upon ligand activation
featuring hyperproliferation of keratinocytes, dendritic cell accu-
mulation, and endothelial cell activation [41]. Consistent with this
model, we observed a 10-fold elevation in SKO mice of the direct
PPARdtarget heparin-binding EGF-like growth factor (Hbegf;
Table 7), which is elevated in psoriasis and induces epidermal
hyperplasia [56]. The EGF-family ligand TGF-a (Tgfa) and the
kinase Ptk6, which are also increased in both psoriasis and PPARd
transgenic mice, were elevated in SKO mice as well (Table 7)
[41]. Thus, the elevated retinoic acid levels in the skin of SKO
mice may be transactivating both RAR and PPARd.
Inhibition of SCD in SEB-1 sebocytes elevates retinoic
acid-induced genes including LCN2
Interestingly, the skin of SKO mice displayed a 27.7-fold
elevation in the expression of Lcn2 (Table 12), which has
previously been shown to be a retinoic acid-induced gene linked to
sebocyte apoptosis in human SEB-1 cells [57]. We used the
immortalized human sebocyte line SEB-1 as a model to assess the
role of SCD in regulating retinol metabolism in vitro. SEB-1
sebocytes have measurable SCD activity that can be inhibited by
the small molecule A939572 (Figure S1). SEB-1 cells treated with
1 mM A939572 and 1 mM retinol for 24 h displayed a 3-fold
increase in the retinoic acid-induced target genes RBP1, LRAT and
LCN2 (Figure 3A). These genes were not elevated in cells treated
for 24 h with 1 mM retinol alone. Although treatment with
A939572 alone for 24 h did not elevate LCN2, prolonged
treatment for 72 h caused a 9-fold upregulation of LCN2 mRNA
and protein (Figure 3B and 3C). The difference between 24 and
72 hours may be due to cellular retinol accumulation following
media replacement at 48 hours. At all retinol concentrations tested
(0.01 to 10 mM), LCN2 protein secreted into the media was higher
in cells treated with A939572 (Figure S1). As expected, the
expression of DGAT1 was unaffected by retinol and/or A939572
treatment. These data support a direct role of sebocyte SCD
activity in controlling retinol metabolism to prevent an increase in
cellular retinoic acid and RAR-regulated target genes.
Changes in retinoic acid and inflammatory genes occur
in the first hair cycle
Hair follicle cycling begins at around 17 days postnatal in mice,
characterized by the occurrence of the first catagen and telogen
Figure 2. Altered retinoid homeostasis in SKO mice. A) Skin retinol and retinoic acid, as well as B) skin retinyl esters (RE) in male mice fed the
standard diet (SD). *=p,0.05 for lox vs. SKO, n=7–8 per group. C) Plasma retinol levels and D) liver RE levels in male mice fed either SD (n=7–8 per
group) or a retinoid-deficient (RD) diet (n=6 per group). Data represent mean 6 SEM. #=p,0.05 for SD vs. RD within same genotype.
doi:10.1371/journal.pone.0019734.g002
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weeks after birth [58,59]. Scd1 expression has previously been
shown to be low at birth, increase dramatically at around 8 days
postnatal during the completion of hair follicle morphogenesis and
then cycle between high and low expression during the anagen
and catagen/telogen phases of the hair cycle, respectively [6]. We
analyzed the expression pattern of retinoic acid-regulated genes
(Rbp1, Crabp2 and Lcn2) and inflammatory genes (Il1b and Tnf)i n
23 day postnatal skin between Lox and SKO. Consistent with our
microarray observations in older mice, these retinoic acid-
regulated and inflammatory genes were significantly elevated in
SKO mice (Figure 4). This highlights that disturbed retinoic acid
metabolism and inflammation in SKO mice precedes adulthood
and may be the primary insults causing local and systemic changes
in these mice.
Discussion
The primary goal of this study was to determine the mechanism
by which reduced sebaceous gland MUFA production elicits a
profound hypermetabolic whole-body phenotype. Mice with a
targeted deletion of Scd1 have a dysfunctional epidermal lipid
barrier that results in increased transepidermal water loss (TEWL)
and has been suggested to be the source of the hypermetabolism
[8,13]. Interestingly, artificial occlusion of the skin of Scd1-deficient
mice with topical application of petroleum jelly largely reversed
the cold intolerance, high TEWL and increased O2 consumption
and CO2 production [13]. We investigated whether maintaining
SKO mice at thermoneutral temperature would correct the
hypermetabolic phenotype and render the SKO mice susceptible
to diet-induced obesity. However, SKO mice remained lean and
hyperphagic, similar to those maintained at ambient temperature
[7]. Although the elevated temperature in the thermoneutral
environment likely negates heat loss due to convection, conduction
and radiation, the humidity in the thermoneutral environment
(30–40%) may have still permitted heat loss due to evaporation
that contributed to the obesity resistance.
Interestingly, Scd1
ab-2J, but not Scd1
ab-J mice, with naturally
occurring mutations in Scd1 also have increased TEWL similar to
mice with a targeted deletion of Scd1 [8,13]. Studies that directly
compared the Scd1
ab-2J and Scd1
ab-J mice reported that although
both strains have increased dermal inflammation and reduced
stratum corneum hydration, these phenotypes are more severe in
Scd1
ab-2J compared to the Scd1
ab-J mice [5,8]. These results suggest
inflammation and/or stratum corneum hydration may be involved
in the TEWL phenotype, but that other genetic modifiers may
Figure 3. Loss of SCD1 activity in SEB-1 sebocytes increases
retinoic acid target gene induction. A) SEB-1 human sebocytes
were treated with vehicle alone, the SCD inhibitor A939572 (A939;
1 mM), free retinol (ROH; 1 mM), or both A939 and ROH for 18 hours.
Total RNA was collected for assessment of expression of RBP1, LCN2,
LRAT and DGAT1. Data are expressed relative to vehicle treated cells. B)
SEB-1 cells were grown for the indicated times in the presence or
absence of A939572 (A939; 1 mM) and total RNA was collected for
assessment of LCN2 induction. C) Cellular protein expression of LCN2
increased after 72 hour treatment with A939 as well. Data represent
mean 6 SEM for n=3 per group. *=p,0.05 vs. vehicle control.
doi:10.1371/journal.pone.0019734.g003
Figure 4. Elevated retinoic acid metabolism and inflammatory
genes in 23 day old SKO skin. RNA was isolated from skin of 23 day
old postnatal Lox and SKO mice and subjected to real-time PCR analysis
and normalized to levels of 18S as described in Methods. The expression
of A) retinoic-acid regulated genes (Lcn2, Rbp1, Crabp2)a n dB )
inflammation genes (Il1b, Tnf) were significantly elevated in SKO mice
at 23 days. All values are expressed as fold difference relative to Lox
mice. Data represent mean 6 SEM for n=4–6 per group. *=p,0.05.
doi:10.1371/journal.pone.0019734.g004
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deficiency. Treatment of Scd1
ab mice with the immunosuppressant
drug cyclosporine A reduces inflammation, epidermal thickness
and hyperkeratosis, and restored some hair growth [60]. We
observed a remarkable enrichment of genes involved in the
inflammatory process, supporting the involvement of inflamma-
tion in the progression of the skin phenotype. Since TEWL is
known to increase under conditions of skin irritation and
dermatitis [61,62], it is possible that the primary mechanism for
the hypermetabolism is due to a pro-inflammatory stimulus in the
skin.
The decreased stratum corneum hydration in Scd1-deficient
mice has been suggested to be due to reduced glycerol content that
results from diminished sebaceous gland-derived triglyceride
hydrolysis [5]. In support of this model, we observed robust
repression of genes encoding transcription factors and enzymes
involved in fatty acid and triglyceride synthesis, triglyceride
hydrolysis and sebocyte differentiation. Although there may be
less sebaceous gland-derived glycerol due to Scd1 deficiency, we
observed a marked increase in Aqp3 and Aqp9, two aquaglycer-
oporins essential for normal glycerol transport and metabolism
[63,64] (Table S2). This may serve as an adaptation to low
glycerol availability to help maintain normal glycerol status. It has
also been suggested that a deficiency of epidermal ceramides
containing very long-chain fatty acids, due to decreased elongase
expression, contributed to the epidermal barrier disruption [13].
Consistent with these results, we also found a dramatic repression
of several elongase genes. Combined with an overall reduced
capacity for fatty acid synthesis, the reduced elongase expression
would be predicted to severely compromise very long chain fatty
acid synthesis.
We unexpectedly found an elevation in skin retinol and retinoic
acid levels as well as a marked elevation in retinoic-acid responsive
genes due to skin Scd1 deficiency. This is reminiscent of Dgat1-
deficient mice, which have been shown to have a reduced capacity
for skin retinol esterification leading to elevated levels of skin
retinol and retinoic acid, and resulting in cyclical hair loss [48].
Although LRAT is the major retinyl ester synthesizing enzyme in
most cells, in vivo studies by O’Byrne et al. in Lrat-deficient mice
support the existence of a physiologically significant ARAT
activity for retinyl ester formation [65]. Indeed, Wongsiriroj et al.
first confirmed the physiological relevance of an ARAT activity for
DGAT1 using mice deficient in both Lrat and Dgat1 [66].
Kurlandsky et al. proposed that LRAT acts primarily in the basal
keratinocytes of the skin, whereas retinyl ester synthesis in the
differentiating suprabasal keratinocytes is predominantly derived
from an ARAT activity [47]. Therefore, certain cells in the skin,
such as the suprabasal keratinocytes and possibly sebocytes, may
have a greater dependency on ARAT activity for retinyl ester
formation. We speculate that MUFA, which are important
substrates for DGAT1-mediated triglyceride formation, are also
an important substrate for retinyl ester formation in cells that have
a greater reliance on ARAT activity for retinyl ester synthesis.
Since our studies are performed in whole-skin, the retinyl esters,
retinol and retinoic acid might all be compartmentalized in
different places. The accumulated retinol in the skin of SKO mice
may be localized to a compartment that is inaccessible to LRAT,
and subsequently converted to retinoic acid. Furthermore, the
accumulated retinoic acid could possibly diffuse out and
upregulate LRAT-mediated retinyl ester formation in different
cells. Alternatively, retinyl ester hydrolase(s) may become active,
resulting in a futile cycle where retinyl esters are made and then
hydrolyzed. The persistent elevation in skin retinoic acid levels
could also be due to decreased retinoic acid catabolism. We
observed robust suppression of Cyp2e1 and Cyp1a1, which encode
two cytochrome P450 enzymes that can catalyze retinoic acid 4-
hydroxylase activity in murine skin [51,52].
Despite reducing liver retinol stores by more than 400-fold with
a RD diet intervention in both Lox and SKO mice, we were
unable to normalize skin retinoic acid levels and normal hair
growth in SKO mice. In contrast, studies by Shih et al. in Dgat1-
deficient mice were able to normalize skin retinoic acid levels and
hair growth with a similar intervention [48]. This may indicate
that lack of Scd1 causes a more pronounced alteration in retinoic
acid metabolism. Consistent with this notion, the skin phenotype
elicited by Scd1 deficiency is more severe than that observed due to
Dgat1 deficiency [48]. Alternatively, non-retinoid pathways may
also be contributing to the skin phenotype. MUFAs are also
important for cellular cholesterol ester synthesis [11] and SKO
mice have elevated levels of skin free cholesterol [18]. Thus, a
decrease in MUFA availability may affect both cholesterol and
retinol homeostasis, in addition to triglyceride synthesis.
The therapeutic and pathological effects of retinoids on the skin
have been known for many years. In vivo, both topical and orally
administered retinoids stimulate keratinocyte proliferation and
differentiation, resulting in increased number of epidermal cell
layers and epidermal thickness, widening of spaces between
keratinocytes and changes in the thickness and organization of
the stratum corneum [67,68,69]. Furthermore, retinoid treatment
causes a dose-dependent increase in TEWL, potentially due to
loosening and fragility of the stratum corneum [68,70]. The high
responsiveness of various skin cells, such as epidermal keratino-
cytes, follicular keratinocytes, and sebocytes, to retinoid treatment
is explained by their prominent expression of enzymes, binding
proteins, and nuclear receptors involved in retinoic acid synthesis
and signaling [71].
One of the most well-studied retinoid drugs is isotretinoin (13-cis
retinoic acid), which likely acts as a prodrug that becomes
selectively activated in the sebocyte possibly after isomerization to
tretinoin (all-trans retinoic acid) [72]. Isotretinoin treatment causes
apoptosis and reduced size of the sebaceous gland, and the
sebocytes appear undifferentiatied and have decreased lipid
accumulation [2,73]. We propose that the elevated levels of all-
trans retinoic acid in the skin of SKO mice leads to sebaceous gland
dysfunction. As previously suggested by Sundberg et al., the
sebaceous gland dynsfunction due to Scd1-deficiency impairs the
degradation of the inner root sheath causing restraint and
destruction of the hair follicle, inducing an inflammatory reaction,
epidermal hyperplasia and scarring alopecia [8].
Skin biopsies taken from patients treated with isotretinoin also
showed high expression of LCN2 (lipocalin-2) [57,73]. Addition-
ally, isotretinoin treatment of SEB-1 human sebocyte cultures
causes cell cycle arrest and apoptosis concomitant with increased
expression of LCN2 [72,74]. SEB-1 cells were rescued from
isotretinoin-induced apoptosis upon siRNA knockdown of LCN2
[57]. The LCN2 promoter has binding sites for both RAR and
retinoid-X-receptor (RXR), suggesting that the toxic effect of
retinoic acid on sebocytes is occurring via a lipocalin-2-mediated
mechanism [57]. Since we observed a robust 27.7-fold elevation of
Lcn2 in the skin of SKO mice, it is possible that the primary
disturbance in the skin of SKO mice is retinoic acid-induced Lcn2
leading to sebocyte dysfunction and sebaceous gland hypoplasia.
However, Lcn2 is also increased in lesional compared to non-
lesional skin samples from psoriasis patients, as well as increased in
the skin of a murine model of PPARd hyperactivation with a
psoriasis-like condition [41]. Therefore, the increased Lcn2 in
SKO mice may be influenced not only by retinoic acid, but also by
the secondary effects of inflammation [75]. Alternatively,
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transcription factors involved in lipid synthesis in SKO mice may
also contribute to sebaceous gland hypoplasia. Future studies are
required to ascertain which of these potential mechanisms is
responsible for the skin phenotype of the SKO mice.
In summary, we have shown that SCD1 is essential for normal
retinoid homeostasis in the skin. Lack of skin SCD1 causes an
elevation in skin levels of retinol and retinoic acid, which in turn
activates the transcription of retinoic acid-induced genes. We
speculate that one of these elevated retinoic acid-induced genes,
Lcn2 (lipocalin-2) results in sebocyte dysfunction and sebaceous
gland hypoplasia in the SKO mice. Additionally, lack of SCD1
causes decreased fatty acid synthesis gene expression in the skin
concomitant with elevated cholesterol synthesis. This pattern
suggests a state of disturbed lipid metabolism that may also
contribute to the skin phenotype. The disturbed retinol metabo-
lism and inflammatory gene expression is also evident at 23 days
postnatal, highlighting that Scd1 is essential for early events in
sebocyte development and normal hair cycling.
Methods
Animals and diets
Scd1
flox/flox (Lox) and Scd1
flox/flox;Krt14-Cre/+ (skin-specific Scd1
knockout; SKO) mice on a C57BL/6J background were generated
as previously described [7]. All mice used in this study were male
unless otherwise stated. Mice were housed in a controlled
environment (21uC; 30–40% relative humidity) with 12 h light
and dark cycles and fed a standard diet (PMI 5008 Formulab;
Purina Mills Nutrition International, Richmond, Indiana) unless
otherwise stated. Animal experiments were approved by the
Animal Care Research Committee of the University of Wisconsin-
Madison under protocol A00625. For diet-induced obesity
experiments under thermoneutral conditions, mice were trans-
ferred at 6 weeks of age to a controlled environment (32.5–33.5uC;
30–40% relative humidity), allowed to acclimate for 2 weeks and
then fed a high-fat diet (Harlan TD.06414; 60% kcal fat) for 7
weeks. Retinol deficiency was induced by feeding pregnant dams a
retinoid-deficient (RD) diet (Harlan TD.09238; 10% kcal fat;
,0.04 IU retinol/g) throughout gestation and suckling. The third
consecutive litter from dams maintained continuously on the RD
diet were weaned and maintained on the RD diet until
approximately 10 weeks of age.
Collection of gene expression data
Dorsal skin of 8 to 9 week-old non-fasted male mice fed a
standard diet was shaved with electric clippers prior to sacrifice.
Mice were sacrificed by isoflurane overdose in the early light cycle
and dorsal skin, liver, adipose tissue and plasma were immediately
frozen in liquid nitrogen. Total RNA was extracted from whole
skin using TRI reagent (Molecular Research), and treated with
TURBO DNase (Ambion) before being subjected to microarray
studies. Affymetrix Mouse 430 2.0 microarray chips were used to
monitor the expression level of 45,101 probe sets representing over
39,000 transcripts and variants from over 34,000 mouse genes
(Affymetrix). All microarray data are MIAME compliant and are
deposited as Gene Expression Omnibus accession GSE24243,
which may be accessed at http://www.ncbi.nlm.nih.gov/geo.
Gene abbreviations are defined in accordance with the Human
Gene Nomenclature Committee [76]. RNA isolated from 23 day
old skin samples or SEB-1 cell cultures was reverse transcribed
using Mutliscribe reverse transcriptase (Applied Biosystems) and
subjected to real-time PCR on the ABI Prism 7500 Fast
instrument using Power SYBR Green master mix (Applied
Biosystems) and 18S as a normalization gene. The primer
sequences are available upon request.
Pre-Processing and Statistical Analysis of Gene
Expression Data
Expression measurements were pre-processed to provide
background correction, normalization and log base 2 transforma-
tion using RMA (Robust Multi-array Average) [77]. We used two
analytical approaches to generate lists of differentially expressed
probe sets, loosely referred to as genes. First, we calculated an un-
moderated t-statistic for every probe set by applying Welch’s t-test.
The resulting p-values were used to calculate q-values, which
account for multiple tests and provide thresholds so that lists can
be generated for a target false discovery rate (FDR) [78]. Using
this method, we targeted a FDR of 5% and probe sets with q-
values below 0.05 are considered to be of interest.
We also applied EBarrays [79,80], which along with RMA is
implemented in R, a publicly available statistical analysis
environment [81] and available at Bioconductor [82]. EBarrays
is an empirical Bayes approach which models the probability
distribution of a set of expression measurements [79,80]. It
accounts generally for differences among probe sets in their true
underlying expression levels, measurement fluctuations and
distinct expression patterns for a given probe set among conditions
[79]. An expression pattern is an arrangement of the true
underlying intensities (m) in each condition. The number of
patterns possible depends on the number of conditions from which
the expression measurements were obtained. For example, when
measurements are taken from two conditions, two patterns of
expression are possible: equivalent expression (EE; m1=m2) and
differential expression (DE; m1?m2). Since we do not know a priori
which probe sets are in which patterns, the marginal distribution
of the data is a mixture over the possible patterns with model
parameters determined by the full set of array data. In this way,
the approach utilizes information across a set of arrays to optimize
model fit and is thus more efficient than a number of methods that
make inferences one probe set at a time [79]. The approach also
naturally controls for both type I and type II errors [79]. The fitted
model parameters provide information on the number of probe
sets expected in each expression pattern. Furthermore, the fitted
model is used to assign posterior probability distributions to every
probe set. Each probe set specific distribution gives the posterior
probability of that probe set’s individual expression pattern. The
posterior expected FDR is controlled by thresholding the posterior
probabilities. Two approaches were used as discussed in [83]. The
most conservative approach to control the FDR at 5%, for
example, is to only consider probe sets with specific posterior
probability of EE less than 0.05 (hard threshold). We also report
results from the less conservative approach that determines the
exact threshold required (soft threshold) so that the average
posterior probability of EE for all probe sets on a list is less than
0.05.
Tests for enrichment of common function among sets of
differentially-expressed probe sets were carried out using data from
the Gene Ontology (GO) annotations and the Kyoto Encyclopedia
of Genes and Genomes (KEGG). The R package allez was be used
to perform tests of enrichment for each GO category and KEGG
pathway [84]. In general, the interpretation of p-values resulting
from hypergeometric-based enrichment tests is not straightforward
due to the many dependent hypotheses tested. Furthermore, the
enrichment test tends to result in small p-values when groups with
few probe sets are considered. The statistical methods underlying
allez adjust for these factors, allowing increased power and
sensitivity for identifying sets that are biologically meaningful. We
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set as enriched if its Z-score exceeded 5, as recommended in [84].
High performance liquid chromatography (HPLC)
analysis of retinoids
Reverse phase HPLC analysis of retinol and retinyl esters in
tissues was performed as described elsewhere [85,86]. Briefly, all
samples were flash frozen in liquid N2 immediately after collection.
Liver, skin and adipose tissues were first homogenized in 10
volumes of PBS (10 mM sodium phosphate, pH 7.2, 150 mM
sodium chloride) using a Polytron homogenizer (Brinkmann
Instruments, Westbury, NY) set at half-maximal speed for 10 s.
200 ml of the homogenate or 100–200 ml of plasma was treated
with an equal volume of absolute ethanol containing a known
amount of retinyl acetate as an internal standard, and the retinoids
present in the homogenates were extracted into hexane. The
extracted retinoids were separated on a 4.66250-mm Ultrasphere
C18 column (Beckman, Fullerton, CA) preceded by a C18 guard
column (Supelco, Bellefonte, PA), using 70% acetonitrile-15%
methanol-15% methylene chloride as the running solvent, flowing
at 1.8 ml/min. Retinol and retinyl esters (routinely, retinyl
palmitate, oleate, linoleate, stearate) were identified using a Waters
2996 photodiode array detector to compare retention times and
spectral data of experimental compounds with those of authentic
standards. Concentrations of retinol and retinyl esters in these
samples were quantitated by comparing integrated peak areas of
the unknowns against those of known amounts of purified
standards. An internal standard, retinyl acetate, added immedi-
ately after homogenization of the samples, was used to correct for
losses during extraction.
Determination of tissue levels of all-trans-retinoic acid
Tissue levels of all-trans-retinoic acid were determined by ultra
performance liquid chromatography tandem mass spectrometry
(UPLC/MS/MS). For this purpose, we employed LC/MS grade
acetonitrile, hexane, and water purchased from Fisher Scientific
(Pittsburgh, PA). All-trans-retinoic acid was purchased from Sigma-
Aldrich. Penta-deuterated all-trans-retinoic acid (atRA-d5) was
employed as an internal standard and was purchased from
Toronto Research Chemicals (North York, Ontario). Retinoid
concentrations of standards were verified spectrophotometrically
using published e values [87]. Tissue homogenates were extracted
using the two-step acid-base extraction described by Kane et al.
[88]. Briefly, 0.5 ml of 0.025 M KOH in ethanol was added to
250 ml tissue homogenate prepared from 50 mg of wet tissue. Five
ng of atRA-d5 dissolved in absolute ethanol was added to each
tissue homogenate as internal standard. Retinoids present in this
mixture were extracted into 5 mL of hexane (LC/MS grade,
Fisher). Following centrifugation to separate phases, the upper
organic phase containing nonpolar retinoids (retinol and retinyl
esters) was removed. Thirty ml of 4 M HCl was then added to the
aqueous phase and polar retinoids like all-trans-retinoic acid were
extracted into 5 mL hexane. The retinoid containing organic
phase was removed and dried under nitrogen. The dried extract
was resuspended in 70 ml of acetonitrile (Fisher) and transferred to
an amber LC/MS vial (Waters). Only glass containers, pipettes,
and calibrated syringes were used to handle retinoic acid.
UPLC/MS/MS analyses were carried out on an Waters Xevo
TQ MS ACQUITY UPLC system (Waters, MA). The UPLC/
MS/MS system was controlled by MassLynx Software 4. 1.
Samples were maintained at 4uC in the autosampler and 5 ml
was loaded onto a Waters ACQUITY UPLC HHS C18 co-
lumn (2.1 mm6100 mm, 1.8 mm particles) preceded with a
2.1 mm65 mm guard column containing the same packing
material (Waters). Throughout chromatography, the column was
maintained at 40uC. The flow rate was 300 ml/min employing a
binary gradient the following mobile phase gradient which was
initiated with 32% phase A consisting of H2O (LC/MS grade,
Fisher), containing 0.1% formic acid, and 68% mobile phase B
consisting of acetonitrile, containing 0.1% formic acid. Initial
solvent conditions were maintained for 6.3 minutes, at which time,
the percentage of solvent B was increased linearly to 85% by
6.4 min. This solvent mixture was maintained until 9.5 min when
the percentage of solvent B was increased to 100% to wash the
column. The wash was allowed to continue for 2 min and then
flow was returned to the initial binary gradient consisting of 68%
solvent B. All-trans-retinoic acid eluted between 8.2 and 8.4 min.
Positive electrospray ionization mass spectrometry was performed
using the following parameters: capillary voltage 3.8 kV, source
temperature 150uC, dissolving temperature 500uC, dissolving gas
flow 800 L/hr, collision gas flow 0.15 ml/min. The optimized
cone voltage was 16 V and the collision energy for the multiple
reactions monitoring mode (MRM) was 18 eV. All-trans-retinoic
acid was detected and quantified using MRM employing the
following transitions: all-trans-retinoic acid, 301.16R123.00 m/z;
and atRA-d5, 306.15R127.03 m/z.
SEB-1 Cell Culture
Cells from the SEB-1 human sebaceous gland primary cell line
(obtained from Dr. Diane M. Thiboutot, Penn State Milton S.
Hershey Medical Center) were maintained in DMEM with 10%
FBS and 1% penicillin/streptomycin at 37uC and 5% CO2. Cells
were grown in standard culture conditions until confluence, after
which time the medium was replaced with serum free medium to
eliminate exogenous free fatty acids, notably FBS mediated 18:1
delivery. Cells were treated either with 1 mM or with the indicated
concentrations of free retinol in serum free DMEM for 18 hours,
after which time total RNA was collected and used for assessment
of retinoic acid-mediated gene induction. Free retinol was
dissolved in EtOH in a 10 mM stock under yellow light with all
subsequent dilutions and treatment of cells protected from direct
white light. SCD was inhibited using the small molecule inhibitor
(4-(2-chlorophenoxy)-N-(3-(methylcarbamoyl)-phenyl)piperidine-
1-carboxamide) (A939572) from Biofine International Inc. (Van-
couver, BC, Canada). Working concentrations (1 mM) were
diluted into serum free DMEM prior to assay. Vehicle (control)
treated cells consisted of diluent (DMSO) in serum free DMEM.
Lipocalin-2 protein was detected in cell lysates and media using a
rabbit polyclonal antibody against lipocalin-2 (ab63929) from
Abcam.
Quantification and inhibition of SCD activity in SEB-1 cells
SEB-1 cells were treated with increasing concentrations of
stearate ranging from 0–100 mM stearic acid containing 0.5 mCi
14C stearic acid conjugated to BSA in DMEM containing 1% FBS
for 4 hours. Cells were then collected into 400 ml NaOH and after
addition of 400 ml butylated hydroxytoluene (1.25 mg/ml in
EtOH), cellular lipids were saponified at 85uC for 1 hour. The
mixture was acidified by addition of 540 ml formic acid, and lipids
extracted with 700 ml hexane. Free fatty acids were resolved
on a 10% AgNO3-impregnated silica gel TLC plate using
chloroform:methanol:acetic acid:H2O (90:8:1:0.8). Radioactive
spots were read using a Packard Instant Imager with the upper
band corresponding to
14C stearate and the lower band
14C oleate.
Quantification of SCD-1 activity was determined based on the
intensity of
14C oleate (lower band) formed relative to the
14C
stearate (upper band). Cells were treated with or without the small
molecule SCD inhibitor A939572 (1 mM; Biofine).
SCD1 Is Essential for Skin Retinol Homeostasis
PLoS ONE | www.plosone.org 15 May 2011 | Volume 6 | Issue 5 | e19734Other statistical analyses. Values are reported as mean 6
SEM and were compared by t test or analysis of variance followed
by Bonferroni or Tukey’s Post-hoc test.
Supporting Information
Figure S1 Characterization of SCD1 activity and lipo-
calin-2 secretion in human SEB-1 sebocytes. A) The
relative activity of endogenous SCD1 was measured in SEB-1
sebocytes as described in Methods. SEB-1 sebocytes display
measurable conversion of
14C-stearate into
14C-oleate that is able
to be inhibited by the small molecule SCD1 inhibitor A939572. B)
Increasing concentrations of free retinol were used to measure the
appearance of LCN2 secreted into the media from SEB-1 cells. At
low concentrations, cells with and without SCD1 activity
demonstrated a modest increase in LCN2 secretion. Higher
retinol levels ($1 mM) did not increase LCN2 secretion in cells
with SCD1 activity possibly due to feedback inhibition, whereas
SCD1 inhibited cells continued to increase LCN2 secretion when
treated with up to 10 mM retinol.
(PDF)
Table S1 Inflammation, wound healing and defense
response. Changes in gene expression are reported as fold-
change (FC) relative to Lox mice. Significant differences between
Lox and SKO were determined as described in Methods, and for
both Welch’s t-test and EBarrays the false discovery rate was set at
5%. All probe sets listed have a posterior probability of differential
expression (PP of DE) .0.639 (soft threshold) based upon analysis
by EBarrays. Additionally, Welch’s t-test was used to calculate q-
values and those probe sets with q-values ,0.05 were considered
significant.
(PDF)
Table S2 Miscellaneous categories. Changes in gene
expression are reported as fold-change (FC) relative to Lox mice.
Significant differences between Lox and SKO were determined as
described in Methods, and for both Welch’s t-test and EBarrays the
false discovery rate was set at 5%. All probe sets listed have a
posterior probability of differential expression (PP of DE) .0.639
(soft threshold) based upon analysis by EBarrays. Additionally,
Welch’s t-test was used to calculate q-values and those probe sets
with q-values ,0.05 were considered significant.
(PDF)
Table S3 Proteases and peptidases. Changes in gene
expression are reported as fold-change (FC) relative to Lox mice.
Significant differences between Lox and SKO were determined as
described in Methods, and for both Welch’s t-test and EBarrays the
false discovery rate was set at 5%. All probe sets listed have a
posterior probability of differential expression (PP of DE) .0.639
(soft threshold) based upon analysis by EBarrays. Additionally,
Welch’s t-test was used to calculate q-values and those probe sets
with q-values ,0.05 were considered significant.
(PDF)
Table S4 Collagens, keratins, gap junctions and tight
junctions. Changes in gene expression are reported as fold-
change (FC) relative to Lox mice. Significant differences between
Lox and SKO were determined as described in Methods, and for
both Welch’s t-test and EBarrays the false discovery rate was set at
5%. All probe sets listed have a posterior probability of differential
expression (PP of DE) .0.639 (soft threshold) based upon analysis
by EBarrays. Additionally, Welch’s t-test was used to calculate q-
values and those probe sets with q-values ,0.05 were considered
significant.
(PDF)
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